{
  "hero": {
    "title": "End-to-End Trial Optimization",
    "subtitle": "Experience how AdjuvantIQ transforms clinical development from initial planning through regulatory submission",
    "time_investment": "‚è±Ô∏è 20-25 minutes ‚Ä¢ Complete trial lifecycle ‚Ä¢ Multi-stakeholder perspectives"
  },
  "trial_overview": {
    "title": "Cardiovascular Outcomes Trial",
    "subtitle": "Phase III SGLT2 Inhibitor Study",
    "description": "A comprehensive demonstration of AdjuvantIQ's capabilities across the entire clinical development lifecycle, from initial protocol design through regulatory submission.",
    "key_metrics": [
      "Target Enrollment: 8,000 patients",
      "Duration: 36 months",
      "Primary Endpoint: Cardiovascular death or hospitalization",
      "Regulatory Pathway: FDA Breakthrough Therapy Designation"
    ]
  },
  "workflow_phases": [
    {
      "title": "Protocol Design & Optimization",
      "description": "AI-assisted protocol development with stakeholder alignment",
      "link": "protocol-design.html",
      "icon": "üìã"
    },
    {
      "title": "Site Selection & Portfolio Optimization", 
      "description": "Intelligent site selection and geographic optimization",
      "link": "site-selection.html",
      "icon": "üè•"
    },
    {
      "title": "Adaptive Trial Management",
      "description": "Real-time monitoring and adaptive modifications",
      "link": "adaptive-modifications.html",
      "icon": "üîÑ"
    },
    {
      "title": "Regulatory Strategy & Submission",
      "description": "Regulatory pathway optimization and submission preparation",
      "link": "regulatory-strategy.html",
      "icon": "üìã"
    }
  ],
  "credibility_indicators": [
    {
      "icon": "üéì",
      "text": "Developed with clinical development leaders and regulatory experts"
    },
    {
      "icon": "üìä", 
      "text": "Based on analysis of 50+ cardiovascular trials and regulatory submissions"
    }
  ]
}
